Skip to main content
Erschienen in: Journal of General Internal Medicine 11/2015

01.11.2015 | Original Research

A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work?

verfasst von: Karen L. Margolis, M.D., M.P.H., Stephen E. Asche, M.A., Anna R. Bergdall, M.P.H., Steven P. Dehmer, Ph.D., Michael V. Maciosek, Ph.D., Rachel A. Nyboer, B.A., Patrick J. O’Connor, M.D., M.P.H., Pamala A. Pawloski, Pharm.D., JoAnn M. Sperl-Hillen, M.Dv., Nicole K. Trower, B.A., Ann D. Tucker, B.A., Beverly B. Green, M.D., M.P.H.

Erschienen in: Journal of General Internal Medicine | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

ABSTRACT

Background

It is important to understand which components of successful multifaceted interventions are responsible for study outcomes, since some components may be more important contributors to the intervention effect than others.

Objective

We conducted a mediation analysis to determine which of seven factors had the greatest effect on change in systolic blood pressure (BP) after 6 months in a trial to improve hypertension control.

Design

The study was a preplanned secondary analysis of a cluster-randomized clinical trial. Eight clinics in an integrated health system were randomized to provide usual care to their patients (n = 222), and eight were randomized to provide a telemonitoring intervention (n = 228).

Participants

Four hundred three of 450 trial participants completing the 6-month follow-up visit were included.

Interventions

Intervention group participants received home BP telemonitors and transmitted measurements to pharmacists, who adjusted medications and provided advice to improve adherence to medications and lifestyle modification via telephone visits.

Main measures

Path analytic models estimated indirect effects of the seven potential mediators of intervention effect (defined as the difference between the intervention and usual care groups in change in systolic BP from baseline to 6 months). The potential mediators were change in home BP monitor use, number of BP medication classes, adherence to BP medications, physical activity, salt intake, alcohol use, and weight.

Key Results

The difference in change in systolic BP was 11.3 mmHg. The multivariable mediation model explained 47 % (5.3 mmHg) of the intervention effect. Nearly all of this was mediated by two factors: an increase in medication treatment intensity (24 %) and increased home BP monitor use (19 %). The other five factors were not significant mediators, although medication adherence and salt intake improved more in the intervention group than in the usual care group.

Conclusions

Most of the explained intervention effect was attributable to the combination of self-monitoring and medication intensification. High adherence at baseline and the relatively low intensity of resources directed toward lifestyle change may explain why these factors did not contribute to the improvement in BP.
Literatur
1.
Zurück zum Zitat Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.CrossRefPubMed Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.CrossRefPubMed
2.
Zurück zum Zitat Gillespie CD, Hurvitz KA. Prevalence of hypertension and controlled hypertension - United States, 2007–2010. MMWR Surveill Summ. 2013;62(Suppl 3):144–8.PubMed Gillespie CD, Hurvitz KA. Prevalence of hypertension and controlled hypertension - United States, 2007–2010. MMWR Surveill Summ. 2013;62(Suppl 3):144–8.PubMed
3.
Zurück zum Zitat Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12):1230–8.CrossRefPubMed Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12):1230–8.CrossRefPubMed
4.
Zurück zum Zitat Frieden TR, King SM, Wright JS. Protocol-based treatment of hypertension: a critical step on the pathway to progress. JAMA. 2014;311(1):21–2.CrossRefPubMed Frieden TR, King SM, Wright JS. Protocol-based treatment of hypertension: a critical step on the pathway to progress. JAMA. 2014;311(1):21–2.CrossRefPubMed
5.
Zurück zum Zitat Walsh JM, McDonald KM, Shojania KG, Sundaram V, Nayak S, Lewis R, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44(7):646–57.CrossRefPubMed Walsh JM, McDonald KM, Shojania KG, Sundaram V, Nayak S, Lewis R, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44(7):646–57.CrossRefPubMed
12.
Zurück zum Zitat Margolis KL, Kerby TJ, Asche SE, Bergdall AR, Maciosek MV, O’Connor PJ, et al. Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): a cluster randomized trial. Control Clin Trials. 2012;33(4):794–803. doi:10.1016/j.cct.2012.03.014.CrossRef Margolis KL, Kerby TJ, Asche SE, Bergdall AR, Maciosek MV, O’Connor PJ, et al. Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): a cluster randomized trial. Control Clin Trials. 2012;33(4):794–803. doi:10.​1016/​j.​cct.​2012.​03.​014.CrossRef
13.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. doi:10.1001/jama.289.19.2560.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. doi:10.​1001/​jama.​289.​19.​2560.CrossRefPubMed
15.
Zurück zum Zitat Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996;9(1):1–11.CrossRefPubMed Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996;9(1):1–11.CrossRefPubMed
16.
Zurück zum Zitat Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, et al. Antihypertensive treatment based on blood pressure measurement at home or in the physician’s office: a randomized controlled trial. JAMA. 2004;291(8):955–64. doi:10.1001/jama.291.8.955.CrossRefPubMed Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, et al. Antihypertensive treatment based on blood pressure measurement at home or in the physician’s office: a randomized controlled trial. JAMA. 2004;291(8):955–64. doi:10.​1001/​jama.​291.​8.​955.CrossRefPubMed
18.
Zurück zum Zitat Ralston JD, Cook AJ, Anderson ML, Catz SL, Fishman PA, Carlson J, et al. Home blood pressure monitoring, secure electronic messaging and medication intensification for improving hypertension control: a mediation analysis. Appl Clin Inform. 2014;5(1):232–48. doi:10.4338/aci-2013-10-ra-0079.PubMedCentralCrossRefPubMed Ralston JD, Cook AJ, Anderson ML, Catz SL, Fishman PA, Carlson J, et al. Home blood pressure monitoring, secure electronic messaging and medication intensification for improving hypertension control: a mediation analysis. Appl Clin Inform. 2014;5(1):232–48. doi:10.​4338/​aci-2013-10-ra-0079.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.CrossRefPubMed Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.CrossRefPubMed
20.
Zurück zum Zitat Wessling A, Boethius G. Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology. Eur J Clin Pharmacol. 1990;39(3):207–10.CrossRefPubMed Wessling A, Boethius G. Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology. Eur J Clin Pharmacol. 1990;39(3):207–10.CrossRefPubMed
22.
Zurück zum Zitat MacKinnon DP. Introduction to Statistical Mediation Analysis. New York: Erlbaum; 2008. MacKinnon DP. Introduction to Statistical Mediation Analysis. New York: Erlbaum; 2008.
23.
Zurück zum Zitat Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.CrossRefPubMed Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.CrossRefPubMed
24.
Zurück zum Zitat Muthen LK, Muthen BO. Mplus User’s Guide. 6th ed. Los Angeles, CA: Muthen & Muthen; 2010. Muthen LK, Muthen BO. Mplus User’s Guide. 6th ed. Los Angeles, CA: Muthen & Muthen; 2010.
26.
Zurück zum Zitat Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–8. doi:10.1345/aph.1H018.CrossRefPubMed Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280–8. doi:10.​1345/​aph.​1H018.CrossRefPubMed
Metadaten
Titel
A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work?
verfasst von
Karen L. Margolis, M.D., M.P.H.
Stephen E. Asche, M.A.
Anna R. Bergdall, M.P.H.
Steven P. Dehmer, Ph.D.
Michael V. Maciosek, Ph.D.
Rachel A. Nyboer, B.A.
Patrick J. O’Connor, M.D., M.P.H.
Pamala A. Pawloski, Pharm.D.
JoAnn M. Sperl-Hillen, M.Dv.
Nicole K. Trower, B.A.
Ann D. Tucker, B.A.
Beverly B. Green, M.D., M.P.H.
Publikationsdatum
01.11.2015
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 11/2015
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3355-x

Weitere Artikel der Ausgabe 11/2015

Journal of General Internal Medicine 11/2015 Zur Ausgabe

Letter to the Editor

CMS Reimbursement Reform

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.